Given that D-2HG reportedly possesses a promising anti-glioma effect, we hypothesized that a synergistic relationship might exist between D-2HG and TMZ, rendering IDH1-mutant glioma patients more sensitive to TMZ treatment. This evidence concerns the gene IDH1 and central nervous system cancer.